VAPOR INHALER LEVMETAMFETAMINE NASAL DECONGESTANT, EQUALINE- levmetamfetamine inhalant

Vapor Inhaler by

Drug Labeling and Warnings

Vapor Inhaler by is a Otc medication manufactured, distributed, or labeled by Supervalu Inc., Aphena Pharma Solutions MD, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active ingredient (per inhaler)

Levmetamfetamine 50 mg

Purpose

Nasal decongestant

Use:

for temporary relief of nasal congestion due to:

• the common cold
• hay fever or upper respiratory allergies

Warnings

When using this product

• do not exceed recommended dosage
• temporary burning, stinging, sneezing, or increased nasal discharge may occur
• use of this container by more than one person may spread infection
• do not use for more than 7 days
• use only as directed
• frequent or prolonged use may cause nasal congestion to recur or worsen

Stop use and ask a doctor if symptoms persist

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• the product delivers in each 800 mL of air 0.04 to 0.150 mg of levmetamfetamine
• do not use more often than every 2 hours

• adults and children 12 years of age and over: 2 inhalations in each nostril
• children 6 to under 12 years of age (with adult supervision): 1 inhalation in each nostril
• children under 6 years of age: ask a doctor
• children under 2 years of age: do not use

Other information

• this inhaler is effective for a minimum of 3 months after first use
• keep inhaler tightly closed
• store at 59°-86° F (15°-30° C)

Inactive ingredients

bornyl acetate, camphor, lavender oil, menthol, methyl salicylate

Questions or comments?

1-877-932-7948

Principal Display Panel - 198 mg Blister Pack Label

NDC: 41163-031-01

compare to Original
Vicks® Vapolnhaler®
active ingredient*

EQUALINE®

nasal decongestant

vapor inhaler

levmetamfetamine
(nasal decongestant)

temporary relief of
nasal congestion due to:

• colds hay fever
• upper respiratory allergies

NET WT .007 OZ (198mg)

Principal Display Panel - 198 mg Blister Pack Label

EQUALINE®

NDC: 41163-031-01

nasal decongestant

vapor inhaler

levmetamfetamine (nasal decongestant)

NET WT .007 OZ (198mg)

INGREDIENTS AND APPEARANCE

VAPOR INHALER   LEVMETAMFETAMINE NASAL DECONGESTANT, EQUALINE
levmetamfetamine inhalant

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 41163-031
Route of Administration	NASAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Levmetamfetamine (UNII: Y24T9BT2Q2) (Levmetamfetamine - UNII:Y24T9BT2Q2)	Levmetamfetamine	50 mg

Inactive Ingredients
Ingredient Name	Strength
Bornyl acetate (UNII: 213431586X)
Camphor (Synthetic) (UNII: 5TJD82A1ET)
Lavender oil (UNII: ZBP1YXW0H8)
Menthol (UNII: L7T10EIP3A)
Methyl Salicylate (UNII: LAV5U5022Y)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 41163-031-01	1 in 1 BLISTER PACK	02/24/2021
1		198 in 1 INHALER; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part341	02/24/2021

Labeler - Supervalu Inc. (006961411)

Registrant - Aphena Pharma Solutions MD, LLC (829739833)

Establishment
Name	Address	ID/FEI	Business Operations
Aphena Pharma Solutions MD, LLC		829739833	MANUFACTURE(41163-031)